These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29526503)

  • 21. How can nanotechnology help membrane vesicle-based cancer immunotherapy development?
    Tian X; Zhu M; Nie G
    Hum Vaccin Immunother; 2013 Jan; 9(1):222-5. PubMed ID: 23108359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical models and technologies to advance nanovaccine development.
    Peres C; Matos AI; Moura LIF; Acúrcio RC; Carreira B; Pozzi S; Vaskovich-Koubi D; Kleiner R; Satchi-Fainaro R; Florindo HF
    Adv Drug Deliv Rev; 2021 May; 172():148-182. PubMed ID: 33711401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gold nanoparticle mediated cancer immunotherapy.
    Almeida JP; Figueroa ER; Drezek RA
    Nanomedicine; 2014 Apr; 10(3):503-14. PubMed ID: 24103304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of adjuvants for immunotherapy.
    Circelli L; Tornesello M; Buonaguro FM; Buonaguro L
    Hum Vaccin Immunother; 2017 Aug; 13(8):1774-1777. PubMed ID: 28604160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein-based nanoparticles in cancer vaccine development.
    Neek M; Kim TI; Wang SW
    Nanomedicine; 2019 Jan; 15(1):164-174. PubMed ID: 30291897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy.
    Han HD; Byeon Y; Jang JH; Jeon HN; Kim GH; Kim MG; Pack CG; Kang TH; Jung ID; Lim YT; Lee YJ; Lee JW; Shin BC; Ahn HJ; Sood AK; Park YM
    Sci Rep; 2016 Dec; 6():38348. PubMed ID: 27910914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering New Approaches to Cancer Vaccines.
    Mehta NK; Moynihan KD; Irvine DJ
    Cancer Immunol Res; 2015 Aug; 3(8):836-43. PubMed ID: 26156157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
    Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
    J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph node targeting strategies to improve vaccination efficacy.
    Jiang H; Wang Q; Sun X
    J Control Release; 2017 Dec; 267():47-56. PubMed ID: 28818619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular Bioparticulates with Therapeutics for Cancer Immunotherapy.
    Wang C; Wen D; Gu Z
    Bioconjug Chem; 2018 Mar; 29(3):702-708. PubMed ID: 29227626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of nanostructured drug delivery systems in immunotherapy of cancer: a review.
    Asadi N; Davaran S; Panahi Y; Hasanzadeh A; Malakootikhah J; Fallah Moafi H; Akbarzadeh A
    Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):18-23. PubMed ID: 27196810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen/adjuvant-carrying nanoparticles show promise for vaccine delivery.
    Immunotherapy; 2011 Apr; 3(4):467. PubMed ID: 21463186
    [No Abstract]   [Full Text] [Related]  

  • 33. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.
    Kranz LM; Diken M; Haas H; Kreiter S; Loquai C; Reuter KC; Meng M; Fritz D; Vascotto F; Hefesha H; Grunwitz C; Vormehr M; Hüsemann Y; Selmi A; Kuhn AN; Buck J; Derhovanessian E; Rae R; Attig S; Diekmann J; Jabulowsky RA; Heesch S; Hassel J; Langguth P; Grabbe S; Huber C; Türeci Ö; Sahin U
    Nature; 2016 Jun; 534(7607):396-401. PubMed ID: 27281205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies.
    Dobrovolskaia MA
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31861154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cells as natural adjuvants and modulators of immune response in cancer immunotherapy.
    Alli RS; Khar A
    Indian J Biochem Biophys; 2002 Dec; 39(6):363-7. PubMed ID: 22905392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
    Wei J; Xue W; Yu X; Qiu X; Liu Z
    J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
    Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
    Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paracrine cytokine adjuvants in cancer immunotherapy.
    Pardoll DM
    Annu Rev Immunol; 1995; 13():399-415. PubMed ID: 7612229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent developments in nanocarrier-aided mucosal vaccination.
    Kammona O; Bourganis V; Karamanidou T; Kiparissides C
    Nanomedicine (Lond); 2017 May; 12(9):1057-1074. PubMed ID: 28440707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomaterials as vaccine adjuvants.
    Jones KS
    Biotechnol Prog; 2008; 24(4):807-14. PubMed ID: 19194892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.